Skip to main content
Clinical Trials/NCT02894333
NCT02894333
Terminated
Not Applicable

The Process of Sensory Anticipation in Patients With PARKINSON's Disease

Fondation Ophtalmologique Adolphe de Rothschild2 sites in 1 country1 target enrollmentDecember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Enrollment
1
Locations
2
Primary Endpoint
median score
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

The ideomotor theory of action control is considered to be central to the understanding of human voluntary action. According to the ideomotor theory, an action is represented in terms of its desired sensory effects and actions are selected by internally activating these effect representations. Recent imagery and behavioral studies showed that this anticipated representation of action-effects triggered a "sensory attenuation", meaning a decrease of perceptive performances or a decrease of sensory event-related potentials (ERP) for an expected event. Thus, the sensory attenuation constitutes a relevant behavioral tool to investigate sensory anticipation impairment in patients with Parkinson's disease. In a behavioral paradigm, patients and matched control participants have to perform a perceptive task on predicted visual action-effects mixed with mispredicted visual action effects. Performances should be better in mispredicted visual action effects for control participants only.

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
September 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Parkinson's disease
  • Normal or corrected vision

Exclusion Criteria

  • Other pathology or neurological or psychiatric history
  • Known pregnancy or breastfeeding
  • Absence of affiliation to the French Social Security
  • Person under legal protection
  • Patient's opposition to participate

Outcomes

Primary Outcomes

median score

Time Frame: baseline

scores measured with the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

Study Sites (2)

Loading locations...

Similar Trials